نتائج البحث - "Mario R. Velasco"

1

Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma

المصدر: J Clin Oncol

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f53f50387d5994f75ceeba750e8bc2f9Test
https://doi.org/10.1200/jco.21.00079Test

2

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

المصدر: Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-12 (2020)
Journal of Patient-Reported Outcomes

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1135cca28a668cf4e3397584feace78bTest
http://link.springer.com/article/10.1186/s41687-020-00220-xTest

3

Personalized Management of Chemotherapy‐Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

المؤلفون: Eric P. Winer, Shailly Mehrotra, Alan P. Lyss, Alvaro Moreno-Aspitia, Thomas E. Lad, Elizabeth Gray, Mark J. Ratain, Hope S. Rugo, Kehua Wu, Jogarao V. S. Gobburu, Beth Overmoyer, Clifford A. Hudis, William T. Barry, Deborah Toppmeyer, Manish R. Sharma, Mario R. Velasco

المصدر: The Journal of Clinical Pharmacology. 60:444-452

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Paclitaxel, medicine.medical_treatment, Antineoplastic Agents, Breast Neoplasms, Models, Biological, 030226 pharmacology & pharmacy, Article, Drug Administration Schedule, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Albumins, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Computer Simulation, Pharmacology (medical), Patient Reported Outcome Measures, Dosing, Precision Medicine, Pharmacology, Chemotherapy, Drug Tapering, business.industry, Ixabepilone, Peripheral Nervous System Diseases, medicine.disease, Metastatic breast cancer, Peripheral neuropathy, chemistry, Chemotherapy-induced peripheral neuropathy, Epothilones, 030220 oncology & carcinogenesis, Female, Patient-reported outcome, business, Algorithms

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8533360c7be434c2a015fbfe3fbe58c1Test
https://doi.org/10.1002/jcph.1559Test

4

Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905)

المؤلفون: Mario R. Velasco, Charles Lu, Mary W. Redman, James Gilbert Hueftle, Jieling Miao, Ignacio I. Wistuba, David R. Gandara, Nicholas J. Vogelzang, Shirish M. Gadgeel, Frank V. Fossella, John V. Heymach, Brandy Box-Noriega, Anne S. Tsao, Karen Kelly

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 37, iss 28

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Mesothelioma, Cancer Research, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, SWOG investigators, Pleural Neoplasms, Oncology and Carcinogenesis, Clinical Sciences, and over, Pemetrexed, law.invention, Cediranib, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, 80 and over, Humans, Progression-free survival, Oncology & Carcinogenesis, Aged, Cisplatin, Aged, 80 and over, Chemotherapy, Malignant, business.industry, Mesothelioma, Malignant, ORIGINAL REPORTS, Middle Aged, medicine.disease, Progression-Free Survival, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Quinazolines, Female, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8747aaffb359ac72c1ac8b684af4b6cTest
https://pubmed.ncbi.nlm.nih.gov/31386610Test

5

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117

المصدر: Journal of Clinical Oncology. 35:2745-2753

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13ebf1f5cdfe456bf32a652b5c1f9663Test
https://doi.org/10.1200/jco.2015.66.2510Test

6

Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508)

المؤلفون: Keren Sturtz, James C. Shanks, Martin Fleisher, William Tester, Mario R. Velasco, Charles M. Rudin, Chandra P. Belani, Naoko Takebe, Suzanne E. Dahlberg, Manish Monga, Joan H. Schiller, Christine L. Hann, Suresh S. Ramalingam, Helen X. Chen

المصدر: Cancer. 122:2371-2378

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5f3928d3f73a26856244b98fbe6cd3fdTest
https://doi.org/10.1002/cncr.30062Test

7

Phase II Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemo Naive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905, NCT01064648)

المؤلفون: Karen Kelly, David R. Gandara, Jieling Miao, Brandy Box-Noriega, Mary W. Redman, James Gilbert Hueftle, Ignacio I. Wistuba, Frank Fossella, Shirish M. Gadgeel, Charles Lu, Mario R. Velasco, Nicholas J. Vogelzang, J. Heymach, Anne Tsao

المصدر: SSRN Electronic Journal.

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cancer prevention, business.industry, medicine.disease, law.invention, Cediranib, Pemetrexed, Randomized controlled trial, Cancer Therapy Evaluation Program, Informed consent, law, Internal medicine, medicine, Clinical endpoint, Mesothelioma, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::41ed2740da60e619667bdd6bf3e99697Test
https://doi.org/10.2139/ssrn.3254484Test

8

Cetuximab combined with induction oxaliplatin and capecitabine, followed by neoadjuvant chemoradiation for locally advanced rectal cancer: SWOG 0713

المؤلفون: Aram F. Hezel, Katherine A. Guthrie, Cynthia G. Leichman, Howard S. Hochster, Heinz-Josef Lenz, Matthew A. Beldner, Shannon McDonough, Mario R. Velasco, Kevin G. Billingsley, Stephen R. Smalley, Charles D. Blanke

مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Colorectal cancer, Cetuximab, Kaplan-Meier Estimate, Adenocarcinoma, Proto-Oncogene Mas, Article, Disease-Free Survival, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, Aged, Performance status, business.industry, Rectal Neoplasms, Gastroenterology, Induction chemotherapy, Chemoradiotherapy, Adjuvant, Induction Chemotherapy, Middle Aged, medicine.disease, Interim analysis, digestive system diseases, Neoadjuvant Therapy, Oxaliplatin, Regimen, 030220 oncology & carcinogenesis, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f883377d89e50a9ba6df5e922e379b0dTest
https://europepmc.org/articles/PMC6598683Test/

9

SWOG S0905: A randomized phase II study of cediranib versus placebo in combination with cisplatin and pemetrexed in chemonaive patients with malignant pleural mesothelioma

المؤلفون: Nicholas J. Vogelzang, Mary W. Redman, James Gilbert Hueftle, Charles Lu, Shirish M. Gadgeel, Jieling Miao, Ignacio I. Wistuba, Frank V. Fossella, Mario R. Velasco, John V. Heymach, Anne S. Tsao, David R. Gandara, Brandy Box-Noriega, Karen Kelly

المصدر: Journal of Clinical Oncology. 36:8514-8514

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4254684a288cae39303bd71bb10e2f4bTest
https://doi.org/10.1200/jco.2018.36.15_suppl.8514Test

10

Re: Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients with Bone Metastases: A Randomized Clinical Trial

المؤلفون: Charles L. Shapiro, Andrew L. Himelstein, Mario R. Velasco, Ann M. O'Mara, Drew K. Seisler, Douglas Weckstein, James L. Khatcheressian, John D. Roberts, Charles L. Loprinzi, Jared C. Foster, Rui Qin, Paul J. Novotny, Tracey O'Connor, Ronald S. Go, Stephen Grubbs

المصدر: Journal of Urology. 198:484-484

مصطلحات موضوعية: Male, 0301 basic medicine, Zoledronic Acid, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Pain Measurement, Aged, 80 and over, Bone Density Conservation Agents, Diphosphonates, Imidazoles, Bone metastasis, General Medicine, Middle Aged, Metastatic breast cancer, 030220 oncology & carcinogenesis, Spinal Fractures, Female, Multiple Myeloma, medicine.drug, Adult, medicine.medical_specialty, Urology, MEDLINE, Breast Neoplasms, Bone Neoplasms, Bone and Bones, Drug Administration Schedule, Article, 03 medical and health sciences, Breast cancer, Text mining, N-terminal telopeptide, Internal medicine, medicine, Humans, In patient, Dosing, Brief Pain Inventory, Aged, business.industry, Prostatic Neoplasms, medicine.disease, Surgery, 030104 developmental biology, Zoledronic acid, Sample Size, Interval (graph theory), Osteonecrosis of the jaw, business, Spinal Cord Compression

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9227a7abd89ebcf50e73c62ebfe10244Test
https://doi.org/10.1016/j.juro.2017.06.009Test

تنقيح النتائج